What Sildenafil Pentafarma Treats: Main Uses and Benefits

Sildenafil Pentafarma is applied across domains where additional symptomatic support is needed, addressing conditions marked by significant functional strain.

Targeting Impaired Erection Capacity

This medication is centrally used to help manage functional symptoms related to erectile dysfunction, which is characterized by the recurrent inability to achieve or maintain an erection adequate for sexual activity. The therapeutic benefit is connected to the support of the necessary physiological response, providing support that assists with maintaining functional stability and easing the overall impact of this condition on intimacy.

Managing Cardiopulmonary Functional Limitations

Sildenafil Pentafarma is also commonly used to help with the management of Pulmonary Arterial Hypertension (PAH), a chronic condition involving elevated pressure in the lung arteries. It is applied when the condition leads to symptoms related to physical discomfort, such as shortness of breath and exercise intolerance. A main therapeutic benefit is providing support for the patient's physical ability, contributing to improved exercise capacity and a more manageable experience of day-to-day functioning.

---

Quick Fact: Relief for Functional Strain
Primary Therapeutic Focus: Supports erection capacity and plays a role in managing exercise tolerance in PAH.
Symptom Category: Helps address symptom clusters linked to organ-specific functional stress and systemic imbalance.

Regulatory References

1. NIH StatPearls overview of Sildenafil indications

Sildenafil Pentafarma's eligibility profile, as defined by regulatory documents, is based on a patient's concurrent medication use, underlying health status, and age.

The medicine is strictly contraindicated for individuals taking organic nitrates or soluble guanylate cyclase (sGC) stimulators, due to the risk of severe hypotension. Other absolute contraindications include a history of recent stroke or myocardial infarction, severe hepatic impairment, and pre-existing severe hypotension (blood pressure < 90/50 mmHg). Use is also prohibited in patients who have experienced vision loss due to Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION) or have hereditary degenerative retinal disorders.

Eligibility is defined by indication and age. For erectile dysfunction (ED), the medicine is not indicated for women or for individuals under 18 years of age. For pulmonary arterial hypertension (PAH), eligibility extends to adults and children aged 1 year and over.

Conditional use is required in specific populations. Patients with severe renal impairment or hepatic impairment (non-severe) may require a specific starting amount as drug clearance is reduced. Caution is mandatory for those with anatomical penile deformities or conditions predisposing to priapism, such as sickle cell anemia.

Sildenafil Pentafarma Interactions with other medicines and products

Official regulatory documents detail specific pharmacokinetic and pharmacodynamic interactions for sildenafil. The primary concern relates to the drug's vasodilatory effect being amplified by other agents, leading to specific contraindicated combinations.

---

Classification	Interacting Agents (Examples)
Contraindicated Combinations	Organic Nitrates (e.g., Nitroglycerin, Isosorbide Dinitrate) and Guanylate Cyclase Stimulators (e.g., Riociguat).
Pharmacodynamic Risk	Alpha-blockers and most Anti-hypertensives due to additive blood pressure lowering effects.
Metabolic Risk (CYP3A4)	Potent CYP3A4 Inhibitors (e.g., Ritonavir, Ketoconazole) or CYP3A4 Inducers (e.g., Rifampin).

---

Sildenafil is predominantly cleared by the CYP3A4 enzyme, which means strong inhibitors of this enzyme can significantly increase sildenafil exposure (AUC/Cmax). Regulatory constraints exist, such as the requirement that nitrates must not be administered for at least 24 hours after the last Sildenafil dose. The official profile also notes interactions with non-medicinal substances, including alcohol which may heighten the risk of hypotension, and a high-fat meal which reduces the rate of drug absorption. Furthermore, drug clearance is officially noted as being reduced in patients with severe hepatic or severe renal impairment.

Mechanism of Action: Sildenafil Pentafarma

Sildenafil Pentafarma's action is defined by the competitive inhibition of the Phosphodiesterase type 5 (PDE5) enzyme. This enzyme's function is the rapid degradation, or hydrolysis, of the secondary signaling molecule, cyclic Guanosine Monophosphate (cGMP). By binding to the catalytic site of PDE5, the drug prevents cGMP degradation, thereby elevating its concentration within the smooth muscle cells.

This accumulation of cGMP activates cGMP-dependent protein kinase (PKG). The resulting molecular cascade causes the deactivation of the muscle's contractile proteins, leading to the relaxation of vascular smooth muscle cells. This physiological change results in localized vasodilation, a widening of specific blood vessels that produces an increase in regional blood flow. The entire mechanism is dependent on the prior, localized release of Nitric Oxide (NO) to initiate the pathway; Sildenafil acts only as a potentiator of this existing NO-cGMP signal.

Official Administration Guidelines

Sildenafil Pentafarma is administered through two officially approved routes: orally (via film-coated tablets or suspension) or by intravenous (IV) bolus injection. The IV route is intended only for patients who are temporarily unable to take the oral formulation.

Usage patterns and dosage are determined by the specific condition. When used on an as-needed basis, the recommended oral starting dose is 50 mg, which is limited to a maximum frequency of once per day. This dose may be adjusted within the range of 25 mg to 100 mg based on usage rules.

For continuous scheduled therapy, such as for pulmonary arterial hypertension (PAH), the typical starting dose is 20 mg taken three times a day (TID), with doses separated by 4 to 6 hours. This regimen may be titrated up to a maximum of 80 mg TID.

Dose modifications are recommended for specific patient populations. A starting dose of 25 mg should be considered for as-needed use in older adults (65 years and older) and in patients with severe renal or hepatic impairment. Oral tablets may be taken with or without food. If using the oral suspension, the container must be shaken well (e.g., for at least 10 seconds) before each measured dose. If a scheduled dose is missed, the patient should resume the next dose at the regular scheduled time, without taking a double dose.

Research evidence / Overview of studies for Sildenafil Pentafarma

---

Evidence for use in Impaired Erection Capacity

Research examining the medicine for use in impaired erection capacity has primarily relied on short-term, randomized controlled trials (RCTs) against a placebo. These studies monitored functional outcomes based on standardized patient-reported experiences. Findings describe patterns observed where the group receiving the medicine reported outcomes that were assessed for differences compared to the placebo group. The evidence provides insight into short-term changes, but follow-up durations were limited; therefore, long-term effects are not fully established, and results apply only to the populations studied.

---

Evidence for use in Pulmonary Arterial Hypertension (PAH)

This medicine was studied for its use in managing symptoms of Pulmonary Arterial Hypertension (PAH), a condition marked by functional limitations. RCTs examined outcomes reflecting daily functioning or activity level, primarily using the Six-Minute Walk Distance (6MWD) test. Findings describe patterns where groups receiving the medicine were associated with specific measured changes in distance walked, which were compared to those observed in participants receiving placebo. While the functional capacity outcomes were the subject of the primary research, initial trials were not primarily powered to assess long-term survival, and certainty remains low regarding definitive long-term effects on survival outcomes.

---

Research Limitations and Areas of Uncertainty

The research base is comprehensive regarding its primary outcomes in short-term studies, but certain research limitation frames apply. Long-term durability is challenging to establish due to the reliance on open-label and observational cohorts, meaning the persistence of short-term patterns over long periods is not definitively established. Furthermore, the medicine was evaluated in pediatric patients with PAH, but data for certain groups remain insufficient, and subgroup findings are uncertain due to modest sample sizes and lacking comparative evidence. Research provides context but not individual predictions, and studies help show what has been observed so far under controlled conditions.

Key Studies & References

1. Sildenafil in Treatment-Naïve Children, Aged 1 to 17 Years, With Pulmonary Arterial Hypertension – Extension Study (STARTS-2) and FDA/EMA Regulatory Review Context
2. Sildenafil (Revatio) - Pulmonary Hypertension Association (Context for PAH treatment goals and use)

Common questions about Sildenafil Pentafarma (FAQ)

Q: Is Sildenafil Pentafarma the same thing as Viagra?

Sildenafil is the active ingredient found in both Sildenafil Pentafarma and the brand-name medicine, Viagra. Sildenafil is the generic name for the compound. Both products are officially described as treating the same conditions through the same mechanism of action.

---

Q: What Sildenafil Pentafarma is actually used for?

According to official regulatory documents, Sildenafil Pentafarma is approved for two main purposes. It is officially indicated for the treatment of erectile dysfunction (ED). It is also approved for the treatment of pulmonary arterial hypertension (PAH), which is intended to improve exercise ability and delay the worsening of symptoms.

---

Q: Can Sildenafil Pentafarma be used for things other than ED?

Yes, official prescribing information confirms that Sildenafil Pentafarma is also indicated for use in adults for the treatment of pulmonary arterial hypertension (PAH). This is a condition involving high blood pressure in the arteries of the lungs.

---

Q: How quickly does Sildenafil Pentafarma start to work?

Official patient information provides guidance on timing for the as-needed use of the medicine. When used for erectile dysfunction, it is typically taken about 30 minutes to 4 hours before sexual activity. This time frame is provided in official patient information regarding the recommended timing for use.

---

Q: Can I take Sildenafil Pentafarma if I drink alcohol?

Sildenafil has properties that can cause blood vessels to widen, which may lead to lower blood pressure. The official product information notes that alcohol may increase the risk of symptoms such as lightheadedness or dizziness due to enhanced blood pressure-lowering effects.

---

Q: Are there any specific foods I should avoid when using Sildenafil Pentafarma?

Grapefruit or grapefruit juice may affect the amount of Sildenafil in the bloodstream, which is a common interaction seen with medicines processed by certain liver enzymes. Furthermore, official product information states that taking the medicine with a high-fat meal may slow down the rate at which the body absorbs the drug.

---

Q: What happens if Sildenafil Pentafarma doesn't seem to work for me?

Official dosage guidelines note that the starting amount for as-needed use can be adjusted based on the individual's tolerability and the effect achieved. Any adjustment to the amount used is described in official documents as being determined by a healthcare provider.

---

Q: Can women take Sildenafil Pentafarma?

Official indications show a difference based on the condition being treated. The medicine is not indicated for use in women for the treatment of erectile dysfunction. However, it is officially approved and indicated for the treatment of pulmonary arterial hypertension (PAH) in adult women.

---

Q: Does Sildenafil Pentafarma affect fertility?

Studies on healthy male volunteers have examined the effects of a single dose on key fertility factors. Studies on healthy male volunteers have shown that a single oral dose did not have an effect on sperm motility (movement) or morphology (shape).

---

Q: What is the difference between Sildenafil and Sildenafil Pentafarma?

Sildenafil is the name of the active pharmaceutical ingredient, which is also called the generic name. Sildenafil Pentafarma is a specific trade or brand name under which that active ingredient is manufactured and marketed.

---

Q: What is the recommended time frame between doses of Sildenafil Pentafarma?

The recommended time frame depends on the use condition. For as-needed use, the maximum recommended frequency is once per day. For the continuous scheduled treatment of pulmonary arterial hypertension (PAH), official guidelines recommend separating doses by 4 to 6 hours.

---

Q: Are there any long-term effects of using Sildenafil Pentafarma?

Regulatory reviews indicate that the body of clinical evidence is strong regarding the short-term use and outcomes of the medication. However, definitive conclusions regarding long-term durability and persistence of effects are not fully established.

---

Q: Can I take Sildenafil Pentafarma if I have kidney problems?

Regulatory documents indicate that patients with severe renal impairment (significantly reduced kidney function) may require a specific starting amount, as drug clearance is reduced in this patient population.

---

Q: What does 'contraindication' mean in the context of Sildenafil Pentafarma?

A contraindication is a circumstance or condition that officially makes the use of Sildenafil Pentafarma prohibited due to known safety risks. Examples include taking specific medications like nitrates or having certain health issues like severe hypotension (very low blood pressure).

---

Q: Can Sildenafil Pentafarma be taken after a large meal?

Oral tablets can generally be taken with or without food. However, official information notes that taking the medicine with a high-fat meal may reduce the rate of absorption, which can cause the medicine to take longer to start working.

---

Q: Is it typical to experience mild nausea with Sildenafil Pentafarma?

Nausea is a symptom listed in official documents among the commonly reported side effects experienced during clinical use of Sildenafil.

---

Q: Does Sildenafil Pentafarma have any warnings about driving or operating machinery?

Official product information advises that the medicine can cause dizziness or affect vision, and users should be aware of their reaction to the medicine before driving or operating machinery.

---

Q: Are there different forms of Sildenafil Pentafarma available, like liquid or chewable?

The medicine is available in several officially approved forms. these include film-coated tablets for oral use, an oral suspension (liquid), and an injectable solution. Chewable forms are not listed in the official documents.

---

Q: Does Sildenafil Pentafarma interact with herbal supplements?

Official guidance notes that herbal remedies and supplements are not regulated or tested in the same way as prescription medicines. Due to the lack of formal safety testing, it cannot be stated that herbal remedies and supplements are safe to take with Sildenafil Pentafarma.

---

Q: What should I do if a side effect of Sildenafil Pentafarma is listed as 'serious'?

Official patient information describes that if a serious side effect occurs, such as sudden vision loss or sudden hearing loss, the instructions are to stop using the medicine and seek medical attention right away.

---

Q: How long after using Sildenafil Pentafarma should I wait before seeking medical attention for a prolonged erection?

Priapism is defined in official patient information as a prolonged erection lasting more than four hours. Official patient information states that an erection lasting more than four hours (priapism) requires immediate medical attention.

---

How to Store and Dispose of Sildenafil Pentafarma

The storage and disposal of Sildenafil film-coated tablets must strictly follow official regulatory guidelines to maintain product quality and safety.

---

Storage Requirements

Condition	Requirement (Official Labeling)
Temperature	Store below 30 C.
Protection	Keep protected from light and moisture.
Packaging	Store in the original package to ensure environmental protection.
Child Safety	Keep out of the sight and reach of children.

---

Disposal Instructions

Any unused or expired Sildenafil must be disposed of in accordance with local requirements. This typically means the product should not be thrown into household waste or flushed down wastewater, but should be returned to a pharmacy or local collection point for proper pharmaceutical waste handling.